Armata Pharmaceuticals, Inc. Annual Earnings Per Share, Basic in USD/shares from 2013 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2013 to 2023.
  • Armata Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.15 USD/shares, a 82.6% increase year-over-year.
  • Armata Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.14 USD/shares, a 30.5% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -1.91 USD/shares, a 76.9% decline from 2022.
  • Armata Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -1.08 USD/shares, a 12.5% decline from 2021.
  • Armata Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -0.96 USD/shares, a 28.9% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 -$1 -76.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$1 $0 -12.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$1 +$0.39 +28.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$1 +$1.14 +45.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 -$2 +$1.10 +30.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 -$4 -$2 -78.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 -$2 +$22.70 +91.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-25
2016 -$25 -$23 -1140% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-14
2015 -$2 -$6 -147% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
2014 $4.21 +$4.85 Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 -$1 Jan 1, 2013 Dec 31, 2013 10-K 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.